NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
194 hedge funds and large institutions have $2.24B invested in NEVRO CORP. in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 33 closing their positions.
33% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 33
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
6% more funds holding
Funds holding: 183 → 194 (+11)
4% more call options, than puts
Call options by funds: $7.63M | Put options by funds: $7.31M
25% less capital invested
Capital invested by funds: $2.97B → $2.24B (-$729M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$32.3M |
| 2 |
O
OrbiMed
New York
|
+$32.2M |
| 3 |
O
OppenheimerFunds
New York
|
+$24M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.1M |
| 5 |
First Manhattan
New York
|
+$18.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$69.6M |
| 2 |
Millennium Management
New York
|
-$60.5M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$24M |
NVRO Hedge Fund Activity: Q4 2017 in Review
194 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2017, worth a combined $2.24B — down 25% from $2.97B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new NVRO positions and 33 closed out — a net gain of 11 holders — while 66 added to existing stakes and 54 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $32.3M. The largest seller was Citadel Advisors, cutting an estimated $69.6M.
- 194 institutional investors held NEVRO CORP. (NVRO) as of Q4 2017, up from 183 in Q3 2017.
- Funds reported $2.24B of NEVRO CORP. stock for Q4 2017, down 25% quarter-over-quarter.
- 44 funds opened new NEVRO CORP. positions in Q4 2017 and 33 closed out, a net change of +11 holders.
- The largest NEVRO CORP. buyer in Q4 2017 was Janus Henderson Group, an estimated $32.3M added.
- The largest NEVRO CORP. seller in Q4 2017 was Citadel Advisors, an estimated $69.6M sold.
Based on aggregated 13F filings for Q4 2017.